Pricing Log in Create free account

NeuroSense Therapeutics Ltd. (NRSN) vs Heatwurx Inc. (PCSA)

NeuroSense Therapeutics Ltd. and Heatwurx Inc. are both Biotechnology companies. Heatwurx Inc. is the larger, with a market value of $5.2M against $4.6M — 1.1× the size. NeuroSense Therapeutics Ltd. has negative trailing earnings, so its P/E is not meaningful; Heatwurx Inc. trades at 1.8×. Across the 7 metrics below, Heatwurx Inc. leads on 4 and NeuroSense Therapeutics Ltd. on 3.

Valuation

Metric NRSN PCSA Biotechnology median
P/E n/m 1.75 8.58
P/S n/m 38.64 10.29
P/B n/m n/m 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA n/m n/m 0.67
EV/Sales n/m 48.44 9.89
Earnings yield (520.49%) 57.14% (31.56%)
Free cash flow yield (568.39%) (259.68%) (23.42%)

Profitability

Metric NRSN PCSA Biotechnology median
Gross margin — 0.00% 65.77%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (464.19%) (54.09%)
Return on assets 0.00% (262.17%) (47.78%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NRSN PCSA Biotechnology median
Revenue growth (TTM) — (34.50%) 5.83%
EPS growth (last fiscal year) 18.52% 89.29% 29.36%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRSN PCSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.28 0.87 4.80
Net debt to EBITDA 0.01 0.40 0.97

Dividend

Metric NRSN PCSA Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric NRSN PCSA Biotechnology median
Market cap 4.63m 5.20m 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack